Publications by authors named "Shany Or"
Article Synopsis
- This study investigated the effectiveness of TORCH serology testing in pregnant women with suspected infections based on clinical signs, focusing on maternal versus fetal-related reasons for testing.
- Over 10 years, researchers analyzed data from 1,075 women, finding higher rates of TORCH infections, particularly cytomegalovirus (CMV), in those tested for maternal-related symptoms compared to those tested for fetal-related symptoms.
- The results suggest that while the overall benefits of TORCH testing for fetal issues were low, maternal symptoms should prompt testing, especially for CMV and Toxoplasma infections.
Background: The diagnostic yield of TORCH screening for obstetrical indications is unclear. We evaluated TORCH testing results among women with intrauterine growth restriction (IUGR), polyhydramnios and oligohydramnios; and associations with congenital infections in neonates.
Method: This retrospective single-center study included all the women diagnosed with IUGR, polyhydramnios or oligohydramnios who underwent serological TORCH testing during 2010-2019.
Objective: This study aimed to compare obstetrical outcomes between women diagnosed with gestational diabetes mellitus (GDM) in the third trimester after testing negative for GDM in two-step screening in the second trimester and women diagnosed in the second trimester.
Study Design: This retrospective study compared obstetrical outcomes between 375 women diagnosed with GDM in the second trimester and 125 diagnosed in the third trimester.
Results: Among women diagnosed with GDM in the third versus second trimester, the incidences were higher of morbid obesity (body mass index ≥35 kg/m), macrosomia, and cesarean section (CS) due to suspected macrosomia: 23.
Aim: We investigated associations of maternal obesity with late gestational diabetes mellitus (GDM) diagnosis (>34 weeks) in women with previous normal glucose screening, and associations of late GDM with obstetrical outcomes.
Methods: This retrospective cohort study assessed obstetrical and neonatal outcomes of 238 women with normal (24-28 week) glucose screening results, who underwent late repeat oral glucose tolerance tests (OGTT) (>34 weeks) due to a suspected LGA fetus (54.6%) or polyhydramnios (45.
Article Synopsis
- The study investigates the prevalence of gestational diabetes mellitus (GDM) diagnosed in the third trimester and its impact on maternal and neonatal outcomes.
- Out of 372 women tested, 22% were diagnosed with GDM, with a significant portion identified during follow-up after an abnormal oral glucose tolerance test.
- The findings suggest that women with GDM experienced higher rates of complications like large-for-gestational-age babies and higher rates of labor induction, though neonatal outcomes were largely similar between GDM and non-GDM groups.